Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

NCT00014755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: anti-thymocyte globulin
DRUG: cyclophosphamide
DRUG: filgrastim
DRUG: prednisone
PROCEDURE: peripheral blood stem cell transplantation
PROCEDURE: irradiation

Sponsor

Fred Hutchinson Cancer Center